Chiara Dalla Man
Orcid: 0000-0002-4908-0596Affiliations:
- University of Padua, Italy
According to our database1,
Chiara Dalla Man
authored at least 28 papers
between 2002 and 2024.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
Online presence:
-
on orcid.org
-
on dei.unipd.it
On csauthors.net:
Bibliography
2024
Tailoring the Padova Type 2 Diabetes Simulator for Treatment Guidance in Target Populations.
IEEE Trans. Biomed. Eng., June, 2024
The Minimally-Invasive Oral Glucose Minimal Model: Estimation of Gastric Retention, Glucose Rate of Appearance, and Insulin Sensitivity From Type 1 Diabetes Data Collected in Real-Life Conditions.
IEEE Trans. Biomed. Eng., March, 2024
2023
IEEE Trans. Biomed. Eng., September, 2023
2022
IEEE Trans. Biomed. Eng., 2022
Comput. Methods Programs Biomed., 2022
Gluclas: A software for computer-aided modulation of glucose infusion in glucose clamp experiments.
Comput. Methods Programs Biomed., 2022
Glucose Controlin Type 2 Diabetes: In Silico Study of Sub-Optimal Adherence to Insulin Therapy.
Proceedings of the 10th International Conference on Systems and Control, 2022
2021
Proceedings of the 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society, 2021
Modeling Between-Subject Variability in Subcutaneous Absorption of a Long-Acting Insulin Glargine 100 U/mL by a Nonlinear Mixed Effects Approach.
Proceedings of the 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society, 2021
2020
IEEE Trans. Biomed. Eng., 2020
In Silico Cloning of Target Type 2 Diabetes Population for Treatments Development and Decision Support<sup>*</sup>.
Proceedings of the 42nd Annual International Conference of the IEEE Engineering in Medicine & Biology Society, 2020
2019
Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 Diabetes Simulator for In Silico Testing of MDI Therapies.
IEEE Trans. Biomed. Eng., 2019
Physiology-Based Run-to-Run Adaptation of Insulin to Carbohydrate Ratio Improves Type 1 Diabetes Therapy: Results from an In Silico Study.
Proceedings of the 2019 American Control Conference, 2019
2018
IEEE Trans. Biomed. Eng., 2018
Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator<sup>*</sup>.
Proceedings of the 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2018
2016
One-Day Bayesian Cloning of Type 1 Diabetes Subjects: Toward a Single-Day UVA/Padova Type 1 Diabetes Simulator.
IEEE Trans. Biomed. Eng., 2016
IEEE Trans. Biomed. Eng., 2016
2015
Incorporation of inhaled insulin into the FDA accepted University of Virginia/Padova Type 1 Diabetes Simulator.
Proceedings of the 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2015
2014
IEEE Trans. Biomed. Eng., 2014
2012
MPC based Artificial Pancreas: Strategies for individualization and meal compensation.
Annu. Rev. Control., 2012
2011
2009
Model predictive control of glucose concentration in type I diabetic patients: An in silico trial.
Biomed. Signal Process. Control., 2009
2007
2006
IEEE Trans. Biomed. Eng., 2006
Proceedings of the 28th International Conference of the IEEE Engineering in Medicine and Biology Society, 2006
Proceedings of the 28th International Conference of the IEEE Engineering in Medicine and Biology Society, 2006
2002
IEEE Trans. Biomed. Eng., 2002